Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02057432 · ClinicalTrials.gov registry record · NA
Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)
A NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT02057432: Completed NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma, sponsored by Dana-Farber Cancer Institute.
NCT02057432 is a NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02057432, a NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study is a pilot study designed to evaluate magnetic resonance imaging-guided therapy (MRT) as a possible treatment for breast cancer. In this pilot study, the investigators are studying if it is possible to use intra-operative MRI to guide surgery. The therapy takes place in the Advanced Multimodality Image Guided Operating (AMIGO) suite at Brigham and Women's Hospital. The purpose of this study is to investigate if it is possible to perform the breast conserving surgery with the help of intra-operative magnetic resonance imaging in the advanced multimodality image guided operating suite. It is hoped that intra operative MRI may improve the surgeon's ability to know the exact margins of tumor. Currently, approximately 40% of women need to come back to the operating room and have the margins of the cancer re-excised.
Primary Outcome
For the purpose of this pilot study, feasibility is defined as the ability to successfully complete the breast conserving operation in the AMIGO suite. Feasibility must entail the following: All necessary instruments for this operation are MRI compatible or are able to be used safely and then stored outside of the magnetic field when the intra-operative MRI is performed. The intra-operative MRI is performed without compromising the sterile operative field.
Conditions Studied
Interventions
- DEVICE intra-operative MRI
Study Locations (2)
Massachusetts
- Dana-Farber Cancer Institute - Boston
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02057432 record still lists
NCT02057432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Stage II Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which intra-operative MRI is the first listed.
NCT02057432 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02057432 about?
NCT02057432 is a clinical study titled "Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)". This research study is a pilot study designed to evaluate magnetic resonance imaging-guided therapy (MRT) as a possible treatment for breast cancer. In this pilot study, the investigators are studying if it is possible to use intra-operative MRI to guide surgery. The therapy takes place in the Advan...
What is the current status of trial NCT02057432?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-04. Estimated completion is 2016-08.
What conditions does trial NCT02057432 study?
This clinical trial studies the following conditions: Stage II Breast Carcinoma, Stage I Breast Carcinoma.
What interventions are being tested in trial NCT02057432?
The interventions under investigation include: intra-operative MRI (DEVICE).
Who is sponsoring clinical trial NCT02057432?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02057432 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02057432's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia